Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Tokyo  >  Asahi Kasei Corp    3407   JP3111200006

SummaryChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 

Asahi Kasei Corp. : Construction of new acetonitrile plant in Korea

share with twitter share with LinkedIn share with facebook
share via e-mail
0
03/06/2012 | 04:35am CET

Asahi Kasei Chemicals Corp.

Asahi Kasei Chemicals has finalized a decision to construct a new acetonitrile plant in Korea. The plant will have a production capacity of 11,000 tons per year, and start-up is scheduled for January 2014. Having a second production base for acetonitrile, in addition to its Japanese base, will enable Asahi Kasei Chemicals to assure a reliable supply of acetonitrile as demand continues to grow rapidly worldwide.

Acetonitrile is produced by refining the crude acetonitrile obtained as a byproduct of acrylonitrile (AN). It is mainly used as a solvent in the manufacture of pharmaceuticals, with other notable uses including as analytical reagent and in the field of agrichemicals. With an acetonitrile plant in Kawasaki, Kanagawa, Japan, having a production capacity of 14,000 tons per year, Asahi Kasei Chemicals is a major supplier to markets in Asia and Europe as well as Japan. Strong growth in demand for acetonitrile is forecasted, particularly for use in the field of pharmaceutical manufacture. Asahi Kasei Chemicals had therefore been examining how best to increase production capacity and ensure reliable supply as markets continue to grow.

A decision was made to construct a new acetonitrile plant at Tong Suh Petrochemical Corp., Ltd., an Asahi Kasei Group company in Korea, which is currently constructing a new AN plant in Ulsan with startup scheduled for January 2013. The acetonitrile plant in Korea will utilize crude acetonitrile byproduct from the AN plants in Korea.

Having two production bases for acetonitrile, in Japan and Korea, will enable Asahi Kasei Chemicals to provide reliable supply to meet growing demand in the pharmaceutical industry especially in India and China.
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on ASAHI KASEI CORP
12/01 ASAHI KASEI : "Output-Current Detection Chip for Diode Sensors, and Diode Sensor..
11/21 ASAHI KASEI : Zoll Medical Assigned Patent
11/18 ASAHI KASEI : Announcement of listing on the NHI drug price standard and marketi..
11/10 ASAHI KASEI : Researchers Submit Patent Application, "Membrane Module Apparatus,..
11/08 ASAHI KASEI : Home Order Trends – October 2016
11/04 ASAHI KASEI : ZOLL Medical Assigned Patent
10/29 ASAHI KASEI : U.S. Patents Awarded to Inventors in Massachusetts (Oct. 29)
10/28 ASAHI KASEI : ZOLL Medical Assigned Patent
10/20 ASAHI KASEI : Patent Issued for Position Detection Apparatus (USPTO 9467603)
10/19 GLOBAL AND CHINA METHYL METHACRYLATE : Mitsubishi Rayon, Evonik, Dow, Sumitomo C..
More news
Sector news : Commodity Chemicals - NEC
12/02 BRASKEM : Brazil's Braskem shares jump as deal in graft probe seen imminent
11/30 Linde considers fresh merger overture from Praxair
11/29DJLINDE : Praxair Approaches Linde About Resuming Deal Talks -- 2nd Update
11/29DJLINDE : Praxair Approaches Linde About Resuming Deal Talks -- Update
11/29DJLINDE : Praxair Approaches Linde About Resuming Deal Talks
More sector news : Commodity Chemicals - NEC
News from SeekingAlpha
11/12 GMO International Active EAFE Strategy Q3 2016 Commentary
07/05 A YEAR OF SCANDAL : The Beginning Of The End Of Cronyism In Japan?
03/31 Array Bio licenses TrkA inhibitors to Asahi Kasei Pharma in Asia for up to $7..
2015 Polypore merges with Asahi Kasei
2015 REGENERATIVE MEDICINE IN JAPAN : CJ Partners' Colin Lee Novick
Advertisement
Financials ( JPY)
Sales 2017 1 869 085 M
EBIT 2017 -
Net income 2017 91 547 M
Debt 2017 245 846 M
Yield 2017 2,02%
P/E ratio 2017 15,19
P/E ratio 2018 14,13
EV / Sales 2017 0,89x
EV / Sales 2018 0,84x
Capitalization 1 415 941 M
More Financials
Chart ASAHI KASEI CORP
Duration : Period :
Asahi Kasei Corp Technical Analysis Chart | 3407 | JP3111200006 | 4-Traders
Full-screen chart
Technical analysis trends ASAHI KASEI CORP
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 14
Average target price 927  JPY
Spread / Average Target -8,2%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Hideki Kobori President & Representative Director
Ichiro Itoh Chairman
Norio Ichino Independent Director
Masafumi Nakao Director
Yuji Kobayashi Representative Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
ASAHI KASEI CORP24.46%12 402
AIR LIQUIDE-5.59%40 227
LYONDELLBASELL INDUSTR..2.58%36 107
PRAXAIR, INC.16.95%34 178
SHIN-ETSU CHEMICAL CO ..30.76%32 515
AIR PRODUCTS & CHEMICA..24.51%32 026
More Results